Diagnostic Technologies: Page 2

Experts raise concerns about Quest Diagnostics’ consumer-initiated Alzheimer’s test

Experts have raised concerns about Quest Diagnostics’ $399 consumer-initiated Alzheimer’s disease test, telling 360Dx that it is unclear whether the product is accurate enough to support its use.

September 15, 2023

NIH awarding $50.3M to establish multiomics consortium

The U.S. National Institutes of Health (NIH) announced that it will award $50.3 million over five years to establish a multiomics research consortium.

September 14, 2023

Castle Biosciences Pittsburgh lab receives N.Y. state permit

Castle Biosciences has received a clinical laboratory permit from the New York State Department of Health for its Pittsburgh laboratory.

September 13, 2023

Researchers link changes in lipids to human health, disease, and aging

Researchers have tracked changes to lipids during respiratory viral infection, insulin resistance, and aging, suggesting that the fats may play a role in immune homoeostasis and inflammation regulation.

September 13, 2023

Agilent to sell Resolution Bioscience to Exact Sciences

Agilent Technologies has announced that it is selling Resolution Bioscience, its cancer testing business, to Exact Sciences for an undisclosed sum.

September 12, 2023

Identification of hundreds of blood pressure genes lays foundation for hypertension drugs

Researchers have found hundreds of genes that may affect blood pressure, setting the stage for further studies that could inform the development of new treatments for hypertension.

September 12, 2023

Navigate BioPharma, Becton Dickinson collaborate on CDx solutions

Navigate BioPharma and Becton Dickinson have formed a strategic collaboration to use flow cytometry to develop and commercialize companion diagnostics (CDx) and clinical decision-making solutions.

September 11, 2023

Ibex Medical Analytics launches AI-powered breast cancer biomarker scoring platform

Ibex Medical Analytics has launched a breast cancer biomarker scoring tool powered by artificial intelligence (AI) to help clinicians with treatment decisions.

September 11, 2023

Proteomics study finds plasma proteins linked with type 2 diabetes, diabetic complications

An analysis of plasma proteins found to be linked with type 2 diabetes and diabetic complications may help develop therapeutic targets, researchers write in an article published in Cell Reports Medicine.

September 8, 2023

Illumina names new CEO

Illumina has appointed Agilent Technologies’ Senior Vice President Jacob Thaysen as CEO, effective September 25.

September 8, 2023

Actome outlines sequencing expansion plans as EU funding kicks in

Actome has outlined how funding from the European Innovation Council (EIC) will support work to adapt its technology to enable the measurement of “50 to 100 antibodies at the same time in a single cell.”

September 7, 2023

Exact Sciences, Watchmaker Genomics partner to improve DNA methylation technology

Exact Sciences has partnered with Watchmaker Genomics to develop and commercialize technology for analyzing DNA methylation.

September 6, 2023

Previous Page

Page 2 of 299

Next Page